Sandostatin Impairs Postresection Intestinal Adaptation in a Rat Model of Short Bowel Syndrome

被引:0
作者
Igor Sukhotnik
Kamal Khateeb
Michael M. Krausz
Edmund Sabo
Leonardo Siplovich
Arnold G. Coran
Eitan Shiloni
机构
[1] Rappaport Faculty of Medicine,
[2] Technion,undefined
[3] Carmel Medical Center,undefined
[4] Rambam Medical Center,undefined
[5] Ha-Emek Medical Center,undefined
来源
Digestive Diseases and Sciences | 2002年 / 47卷
关键词
sandostatin; intestinal adaptation; short bowel syndrome;
D O I
暂无
中图分类号
学科分类号
摘要
Because of its antisecretory properties, sandostatin has been advocated for the treatment of patients with short bowel syndrome (SBS). This study was conducted to determine the effect of sandostatin on structural intestinal adaptation, cell proliferation and apoptosis in a rat model of SBS. Sprague-Dawley rats were divided into three experimental groups: Sham rats underwent bowel transection, SBS rats underwent 75% small bowel resection, and SBS-sandostatin rats underwent bowel resection and were treated with sandostatin (SBS-SND). Parameters of intestinal adaptation, enterocyte proliferation, and enterocyte apoptosis were determined on day 14 following operation. We have demonstrated that SBS-SND animals demonstrated lower (vs SBS rats) duodenal and jejunal bowel weights, jejunal and ileal mucosal weight, jejunal and ileal mucosal DNA and protein, jejunal and ileal villus height, cell proliferation index in the ileum, and enterocyte apoptosis in jejunum and ileum. We conclude that in a rat model of SBS sandostatin decreases cell proliferation and inhibits structural intestinal adaptation.
引用
收藏
页码:2095 / 2102
页数:7
相关论文
共 89 条
[21]  
Lamers CBHW(1989)Effect of a long acting somatostatin analogue SMS 201–995 on jejunostomy effluents in patients with severe short bowel syndrome Gut 30 943-949
[22]  
Harris AG(1989)The effects of octreotide, soy polysaccharide, codeine and loperamide on nutrient, fluid and electrolyte absorption in the short-bowel syndrome Aliment Pharmacol Ther 3 159-169
[23]  
Arnold R(1984)Inhibitory effects of somatostatin on growth and differentiation in cultured intestinal mucosa Horm Metab Res 16 74-78
[24]  
Simon B(1986)Influence of triamcinolone and somatostatin on morphometric parameters of cultured intestinal mucosa In Vitro Cell Dev Biol 22 647-652
[25]  
Wied M(1991)Somatostatin analogue treatment inhibits post-resectional adaptation of the small bowel in rats Am J Surg 161 107-111
[26]  
Tomassetti P(1993)Somatostatin analogue inhibits intestinal regeneration Arch Surg 128 385-389
[27]  
Migliori M(1985)Influence of somatostatin and bomebesin on plasma enteroglucagon and cell proliferation after intestinal resection in the rat Gut 26 89-94
[28]  
Corinaldesi R(1999)Epidermal growth factor inhibits somatostatin-induced apoptosis J Surg Res 81 95-100
[29]  
Gullo L(undefined)undefined undefined undefined undefined-undefined
[30]  
Arnold R(undefined)undefined undefined undefined undefined-undefined